EN DE
STOCK COMPARISON

Abbott Laboratories vs BIO: Fair Value & Quality

Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and BIO (BIO) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $109 versus a fair value of $74.79 (-31%), while BIO trades at $388 versus $191 (-51%).
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$109
Fair Value$74.79
Quality67/100
BIO
BIO · USD · Health Care
-51%
upside to fair value
overvalued
Price$388
Fair Value$191
Quality67/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Abbott LaboratoriesBIO
Valuation
27.7×P/E (TTM)50.7×
3.89×P/S (TTM)3.15×
3.36×P/B1.09×
15.1×EV/EBITDA19.8×
1.47×PEG1.19×
−31.3%Fair value upside−50.8%
2.2%Dividend yield—
$2.44Dividend per share—
Profitability
13%Operating margin6%
1.19×EBIT margin trend (5Y)0.63×
12%Return on equity3%
6%Return on assets2%
Growth
8%Revenue growth (YoY)1%
0.5%Avg. growth/yr (3Y)-2.7%
5.1%Avg. growth/yr (5Y)0.3%
+10.4%Value creation/yr−23.9%
Balance & size
23.6×Interest coverage (EBIT/interest)5.5×
0.19×Debt / equity0.16×
$175BMarket cap$8B
healthyGrowth qualityweak

Abbott Laboratories leads: 11 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Abbott Laboratoriesof which business quality 66 · market factors 52 BIOof which business quality 66 · market factors 72
ProfitabilityMargins and returns on capital today
50
46
Quality GrowthAre margins and returns improving?
47
57
CashflowEarnings quality: real cash, not paper profit
71
53
Fin. StrengthBalance sheet, leverage, solvency risk
80
69
InvestmentDisciplined investing over empire-building
65
92
Low VolatilityCalm price path (market factor)
83
53
MomentumPrice trend over the last 3–12 months (market factor)
42
76
52W MomentumDistance to the 52-week high (market factor)
34
86
Net IssuanceBuybacks instead of dilution
84
100

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAbbott LaboratoriesPrice $109BIOPrice $388
DCF Models-33%below the price$73.01-46%below the price$208
Earnings-Based-73%below the price$29.42-63%below the price$144
Dividend Discount-63%below the price$39.73n/a
Multiples-35%below the price$70.72-29%below the price$276
Asset-Based-82%below the price$20.05-53%below the price$183
Growth DCF-38%below the price$67.02-59%below the price$158
Economic Profit-66%below the price$37.49-62%below the price$146
Growth Earnings-35%below the price$70.25+33%above the price$517
Minimum-82%below the price$20.05-63%below the price$144
Maximum-33%below the price$73.01+33%above the price$517
Median-51%below the price$53.37-53%below the price$183
Geometric mean-57%below the price$46.36-46%below the price$210

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

BIO: 18 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$109 = current price (white tick)
BIO
Bear $123Fair Value $191Bull $281
$388 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · above median

BIO · Health Care

Quality score67 · Top 25%
Fair value upside-51% · below median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $109 versus a fair value of $74.79 (-31%), while BIO trades at $388 versus $191 (-51%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →
Abbott Laboratories · BIO

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Abbott Laboratories

Abbott Laboratories vs UnitedHealth GroupEli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth Group

Related to BIO

Merck & Company vs UnitedHealth GroupAstraZeneca vs UnitedHealth GroupThermo Fisher Scientific vs UnitedHealth GroupAmgen vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.